Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Novozyme To Set Up Its First Pharmaceutical Company In Tianjin

This article was originally published in PharmAsia News

Executive Summary

Denmark-based Novozyme recently started constructing its biopharmaceutical base in Tianjin's Binhai new district, its first such project in China. This represents the company's second key project after its enzyme formulation plant in the city. With a first phase investment of $70 million, the new facility will mainly produce hyaluronic acid raw drug materials and is expected to start operation by the end of 2010. Novozyme attributes the latest move to Tianjin's solid market conditions and will continue to increase investment if everything goes on track smoothly. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts